Premium
Cervarix, a bivalent HPV vaccine to prevent cervical cancer
Author(s) -
Chaplin Steve,
Nicholas Nick
Publication year - 2008
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.287
Subject(s) - medicine , cervical cancer , bivalent (engine) , gynecology , oncology , cancer , chemistry , organic chemistry , metal
Cervarix, a bivalent vaccine against HPV‐16 and ‐18, is licensed for the prevention of cervical cancer and has been chosen for the HPV immunisation programme. In our New products review, Steve Chaplin presents the clinical data relating to its efficacy and adverse effects, and Mr Nick Nicholas comments on its place in HPV protection. Copyright © 2008 Wiley Interface Ltd